nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—hepatitis B—liver cancer	0.948	1	CtDrD
Entecavir—Hepatocellular carcinoma—Sorafenib—liver cancer	0.00615	0.12	CcSEcCtD
Entecavir—Hepatic cancer—Sorafenib—liver cancer	0.00559	0.109	CcSEcCtD
Entecavir—Ascites—Sorafenib—liver cancer	0.00247	0.048	CcSEcCtD
Entecavir—Lactic acidosis—Epirubicin—liver cancer	0.0017	0.033	CcSEcCtD
Entecavir—Lactic acidosis—Doxorubicin—liver cancer	0.00157	0.0306	CcSEcCtD
Entecavir—Laboratory test abnormal—Epirubicin—liver cancer	0.000993	0.0193	CcSEcCtD
Entecavir—Laboratory test abnormal—Doxorubicin—liver cancer	0.000919	0.0179	CcSEcCtD
Entecavir—Ascites—Epirubicin—liver cancer	0.000913	0.0178	CcSEcCtD
Entecavir—Hepatic failure—Sorafenib—liver cancer	0.000907	0.0176	CcSEcCtD
Entecavir—Ascites—Doxorubicin—liver cancer	0.000845	0.0164	CcSEcCtD
Entecavir—Abdominal pain upper—Sorafenib—liver cancer	0.000744	0.0145	CcSEcCtD
Entecavir—Pancreatitis—Sorafenib—liver cancer	0.000691	0.0134	CcSEcCtD
Entecavir—Transaminases increased—Epirubicin—liver cancer	0.000682	0.0133	CcSEcCtD
Entecavir—Serum creatinine increased—Epirubicin—liver cancer	0.000675	0.0131	CcSEcCtD
Entecavir—Neutropenia—Sorafenib—liver cancer	0.000659	0.0128	CcSEcCtD
Entecavir—Transaminases increased—Doxorubicin—liver cancer	0.000631	0.0123	CcSEcCtD
Entecavir—Serum creatinine increased—Doxorubicin—liver cancer	0.000624	0.0121	CcSEcCtD
Entecavir—Renal failure—Sorafenib—liver cancer	0.000617	0.012	CcSEcCtD
Entecavir—Hepatobiliary disease—Sorafenib—liver cancer	0.000594	0.0115	CcSEcCtD
Entecavir—Hepatomegaly—Epirubicin—liver cancer	0.000586	0.0114	CcSEcCtD
Entecavir—Hepatomegaly—Doxorubicin—liver cancer	0.000542	0.0105	CcSEcCtD
Entecavir—Glycosuria—Epirubicin—liver cancer	0.000512	0.00996	CcSEcCtD
Entecavir—Immune system disorder—Sorafenib—liver cancer	0.000509	0.0099	CcSEcCtD
Entecavir—Alopecia—Sorafenib—liver cancer	0.000498	0.00969	CcSEcCtD
Entecavir—Mental disorder—Sorafenib—liver cancer	0.000494	0.0096	CcSEcCtD
Entecavir—Malnutrition—Sorafenib—liver cancer	0.000491	0.00954	CcSEcCtD
Entecavir—Glycosuria—Doxorubicin—liver cancer	0.000474	0.00921	CcSEcCtD
Entecavir—Leukopenia—Sorafenib—liver cancer	0.000439	0.00854	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000415	0.00807	CcSEcCtD
Entecavir—Anaphylactic shock—Sorafenib—liver cancer	0.000401	0.00779	CcSEcCtD
Entecavir—Infection—Sorafenib—liver cancer	0.000398	0.00774	CcSEcCtD
Entecavir—Nervous system disorder—Sorafenib—liver cancer	0.000393	0.00764	CcSEcCtD
Entecavir—Skin disorder—Sorafenib—liver cancer	0.000389	0.00756	CcSEcCtD
Entecavir—Dyspepsia—Sorafenib—liver cancer	0.000353	0.00685	CcSEcCtD
Entecavir—Gastrointestinal disorder—Sorafenib—liver cancer	0.000346	0.00672	CcSEcCtD
Entecavir—Fatigue—Sorafenib—liver cancer	0.000345	0.00671	CcSEcCtD
Entecavir—Hepatic failure—Epirubicin—liver cancer	0.000335	0.00652	CcSEcCtD
Entecavir—Gastrointestinal pain—Sorafenib—liver cancer	0.000328	0.00637	CcSEcCtD
Entecavir—Abdominal pain—Sorafenib—liver cancer	0.000317	0.00616	CcSEcCtD
Entecavir—Body temperature increased—Sorafenib—liver cancer	0.000317	0.00616	CcSEcCtD
Entecavir—Anaphylactoid reaction—Epirubicin—liver cancer	0.000311	0.00605	CcSEcCtD
Entecavir—Hepatic failure—Doxorubicin—liver cancer	0.00031	0.00603	CcSEcCtD
Entecavir—Anaphylactoid reaction—Doxorubicin—liver cancer	0.000288	0.0056	CcSEcCtD
Entecavir—Asthenia—Sorafenib—liver cancer	0.000287	0.00559	CcSEcCtD
Entecavir—Blood creatinine increased—Epirubicin—liver cancer	0.000282	0.00549	CcSEcCtD
Entecavir—Abdominal pain upper—Epirubicin—liver cancer	0.000275	0.00535	CcSEcCtD
Entecavir—Diarrhoea—Sorafenib—liver cancer	0.000274	0.00533	CcSEcCtD
Entecavir—Dizziness—Sorafenib—liver cancer	0.000265	0.00515	CcSEcCtD
Entecavir—Blood creatinine increased—Doxorubicin—liver cancer	0.000261	0.00508	CcSEcCtD
Entecavir—Pancreatitis—Epirubicin—liver cancer	0.000255	0.00496	CcSEcCtD
Entecavir—Vomiting—Sorafenib—liver cancer	0.000255	0.00495	CcSEcCtD
Entecavir—Abdominal pain upper—Doxorubicin—liver cancer	0.000255	0.00495	CcSEcCtD
Entecavir—Rash—Sorafenib—liver cancer	0.000253	0.00491	CcSEcCtD
Entecavir—Dermatitis—Sorafenib—liver cancer	0.000252	0.00491	CcSEcCtD
Entecavir—Headache—Sorafenib—liver cancer	0.000251	0.00488	CcSEcCtD
Entecavir—Neutropenia—Epirubicin—liver cancer	0.000243	0.00473	CcSEcCtD
Entecavir—Upper respiratory tract infection—Epirubicin—liver cancer	0.000242	0.0047	CcSEcCtD
Entecavir—Nausea—Sorafenib—liver cancer	0.000238	0.00463	CcSEcCtD
Entecavir—Pancreatitis—Doxorubicin—liver cancer	0.000236	0.00459	CcSEcCtD
Entecavir—Hyperglycaemia—Epirubicin—liver cancer	0.000235	0.00457	CcSEcCtD
Entecavir—Renal failure—Epirubicin—liver cancer	0.000228	0.00444	CcSEcCtD
Entecavir—Neutropenia—Doxorubicin—liver cancer	0.000225	0.00438	CcSEcCtD
Entecavir—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000224	0.00435	CcSEcCtD
Entecavir—Haematuria—Epirubicin—liver cancer	0.000221	0.0043	CcSEcCtD
Entecavir—Hepatobiliary disease—Epirubicin—liver cancer	0.00022	0.00427	CcSEcCtD
Entecavir—Hyperglycaemia—Doxorubicin—liver cancer	0.000217	0.00422	CcSEcCtD
Entecavir—Renal failure—Doxorubicin—liver cancer	0.000211	0.0041	CcSEcCtD
Entecavir—Hepatitis—Epirubicin—liver cancer	0.000208	0.00405	CcSEcCtD
Entecavir—Oedema peripheral—Epirubicin—liver cancer	0.000205	0.00399	CcSEcCtD
Entecavir—Haematuria—Doxorubicin—liver cancer	0.000205	0.00398	CcSEcCtD
Entecavir—Hepatobiliary disease—Doxorubicin—liver cancer	0.000203	0.00395	CcSEcCtD
Entecavir—Hepatitis—Doxorubicin—liver cancer	0.000193	0.00375	CcSEcCtD
Entecavir—Oedema peripheral—Doxorubicin—liver cancer	0.00019	0.00369	CcSEcCtD
Entecavir—Immune system disorder—Epirubicin—liver cancer	0.000188	0.00366	CcSEcCtD
Entecavir—Alopecia—Epirubicin—liver cancer	0.000184	0.00358	CcSEcCtD
Entecavir—Mental disorder—Epirubicin—liver cancer	0.000183	0.00355	CcSEcCtD
Entecavir—Malnutrition—Epirubicin—liver cancer	0.000181	0.00353	CcSEcCtD
Entecavir—Immune system disorder—Doxorubicin—liver cancer	0.000174	0.00339	CcSEcCtD
Entecavir—Alopecia—Doxorubicin—liver cancer	0.00017	0.00331	CcSEcCtD
Entecavir—Mental disorder—Doxorubicin—liver cancer	0.000169	0.00328	CcSEcCtD
Entecavir—Malnutrition—Doxorubicin—liver cancer	0.000168	0.00326	CcSEcCtD
Entecavir—Leukopenia—Epirubicin—liver cancer	0.000162	0.00316	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000153	0.00298	CcSEcCtD
Entecavir—Leukopenia—Doxorubicin—liver cancer	0.00015	0.00292	CcSEcCtD
Entecavir—Anaphylactic shock—Epirubicin—liver cancer	0.000148	0.00288	CcSEcCtD
Entecavir—Infection—Epirubicin—liver cancer	0.000147	0.00286	CcSEcCtD
Entecavir—Nervous system disorder—Epirubicin—liver cancer	0.000145	0.00282	CcSEcCtD
Entecavir—Skin disorder—Epirubicin—liver cancer	0.000144	0.0028	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000142	0.00276	CcSEcCtD
Entecavir—Anaphylactic shock—Doxorubicin—liver cancer	0.000137	0.00266	CcSEcCtD
Entecavir—Infection—Doxorubicin—liver cancer	0.000136	0.00265	CcSEcCtD
Entecavir—Nervous system disorder—Doxorubicin—liver cancer	0.000134	0.00261	CcSEcCtD
Entecavir—Insomnia—Epirubicin—liver cancer	0.000134	0.0026	CcSEcCtD
Entecavir—Skin disorder—Doxorubicin—liver cancer	0.000133	0.00259	CcSEcCtD
Entecavir—Somnolence—Epirubicin—liver cancer	0.000132	0.00256	CcSEcCtD
Entecavir—Dyspepsia—Epirubicin—liver cancer	0.00013	0.00253	CcSEcCtD
Entecavir—Gastrointestinal disorder—Epirubicin—liver cancer	0.000128	0.00248	CcSEcCtD
Entecavir—Fatigue—Epirubicin—liver cancer	0.000128	0.00248	CcSEcCtD
Entecavir—Insomnia—Doxorubicin—liver cancer	0.000124	0.00241	CcSEcCtD
Entecavir—Somnolence—Doxorubicin—liver cancer	0.000122	0.00237	CcSEcCtD
Entecavir—Gastrointestinal pain—Epirubicin—liver cancer	0.000121	0.00235	CcSEcCtD
Entecavir—Dyspepsia—Doxorubicin—liver cancer	0.000121	0.00234	CcSEcCtD
Entecavir—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000118	0.0023	CcSEcCtD
Entecavir—Fatigue—Doxorubicin—liver cancer	0.000118	0.0023	CcSEcCtD
Entecavir—Abdominal pain—Epirubicin—liver cancer	0.000117	0.00227	CcSEcCtD
Entecavir—Body temperature increased—Epirubicin—liver cancer	0.000117	0.00227	CcSEcCtD
Entecavir—Gastrointestinal pain—Doxorubicin—liver cancer	0.000112	0.00218	CcSEcCtD
Entecavir—Body temperature increased—Doxorubicin—liver cancer	0.000108	0.0021	CcSEcCtD
Entecavir—Abdominal pain—Doxorubicin—liver cancer	0.000108	0.0021	CcSEcCtD
Entecavir—Asthenia—Epirubicin—liver cancer	0.000106	0.00206	CcSEcCtD
Entecavir—Diarrhoea—Epirubicin—liver cancer	0.000101	0.00197	CcSEcCtD
Entecavir—Asthenia—Doxorubicin—liver cancer	9.83e-05	0.00191	CcSEcCtD
Entecavir—Dizziness—Epirubicin—liver cancer	9.79e-05	0.0019	CcSEcCtD
Entecavir—Vomiting—Epirubicin—liver cancer	9.41e-05	0.00183	CcSEcCtD
Entecavir—Diarrhoea—Doxorubicin—liver cancer	9.37e-05	0.00182	CcSEcCtD
Entecavir—Rash—Epirubicin—liver cancer	9.33e-05	0.00181	CcSEcCtD
Entecavir—Dermatitis—Epirubicin—liver cancer	9.33e-05	0.00181	CcSEcCtD
Entecavir—Headache—Epirubicin—liver cancer	9.27e-05	0.0018	CcSEcCtD
Entecavir—Dizziness—Doxorubicin—liver cancer	9.06e-05	0.00176	CcSEcCtD
Entecavir—Nausea—Epirubicin—liver cancer	8.79e-05	0.00171	CcSEcCtD
Entecavir—Vomiting—Doxorubicin—liver cancer	8.71e-05	0.00169	CcSEcCtD
Entecavir—Rash—Doxorubicin—liver cancer	8.64e-05	0.00168	CcSEcCtD
Entecavir—Dermatitis—Doxorubicin—liver cancer	8.63e-05	0.00168	CcSEcCtD
Entecavir—Headache—Doxorubicin—liver cancer	8.58e-05	0.00167	CcSEcCtD
Entecavir—Nausea—Doxorubicin—liver cancer	8.14e-05	0.00158	CcSEcCtD
